Pharmacy OneSource Logo
Bellevue, Wash. -- Pharmacy OneSource, Inc., application service provider to more than 1,000 hospitals in the United States, announced today that its Quantifi clinical documentation program continues to be successful in helping clients show cost savings, establish benchmarks and trend clinical and quality pharmacy activities. Pharmacy OneSource has 23,005 users currently documenting in Quantifi who have recorded more than $72 million in cost savings in the second quarter of 2007.
Pharmacy OneSource clients documented 1,286,611 interventions last quarter, which were associated with $15,580,957 hard dollars and $56,834,415 soft dollars saved by pharmacists through intervention. Real reduction in supply costs (such as a switch from atorvastatin to simvistatin)
Here are the Top Five Drugs associated with a documented intervention recorded in Quantifi last quarter, and the total number of reports for each:
1. Vancomycin 49642
2. Warfarin 22869
3. Enoxaparin 19150
4. Levofloxacin 16197
5. TPN
With more than 650 hospitals across the world using Quantifi, and more than 10 million clinical interventions, adverse events and adverse drug reactions documented, Pharmacy OneSource understands the potential to increase the credibility of pharmacy numbers in the eyes of the hospital administrators.
Quantifi allows pharmacists to document their clinical interventions, adverse events and adverse drug reactions quickly over the internet or on a handheld computer through a series of menus, drop-lists, and input screens, collecting crucial event data easily. In addition, Quantifi users have the ability to follow-up on their reports or the reports done by their peers. Quantifi Administrators easily generate executive level reports and detailed managerial reports to support clinical and quality improvement activities.
To get a free report, Pharmacy Clinical Interventions Update, with the Top 10 drugs associated with interventions, adverse drug events and medication errors, please submit your contact info at: http://vovici.com/
Photo:
http://www.prlog.org/
